| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.002 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |